A biotechnology company founded in 2015 which operates as a subsidiary of Gilead Sciences and Kite Pharma. The company developed a platform for custom cell engineering called synNotch to be used for anticancer therapies. Their system can also be used to develop cell-based therapies for autoimmune and degenerative disorders.
1
Funding Rounds
$34.4m
Money raised
Name | Phone | Social networks | |
---|---|---|---|
Br*** At**** | - | - | linkedin instagram |
We***** Li* | - | - | - |